| Literature DB >> 31139688 |
Rimona S Weil1,2, Joel S Winston2,3, Louise-Ann Leyland1, Katerina Pappa4, Ribeya B Mahmood1, Huw R Morris5,6, Geraint Rees2,4.
Abstract
OBJECTIVE: Dementia is a common and feared aspect of Parkinson's disease but there are no robust predictors of cognitive outcome. Visuoperceptual deficits are linked to risk of dementia in Parkinson's disease but whether they predict cognitive change is not known, and the neural substrates of visuoperceptual dysfunction in Parkinson's have not yet been identified.Entities:
Mesh:
Year: 2019 PMID: 31139688 PMCID: PMC6529983 DOI: 10.1002/acn3.767
Source DB: PubMed Journal: Ann Clin Transl Neurol ISSN: 2328-9503 Impact factor: 4.511
Demographics of participants
| Controls Mean (SD) | PD Mean (SD) |
|
| |
|---|---|---|---|---|
|
| 10 | 19 | – | – |
| Age (SD), (range) | 64.8 (11.2), (45–78) | 64.2 (6.1), (55–72) | 0.15 (11.9) | 0.88 |
| M/F | 4/6 | 10/9 | 0.4 (1) | 0.52 |
| Disease duration PD (years) | NA | 5.2 (3.5) | – | – |
| H&Y | NA | 1.4 (0.60) | – | – |
| MDS‐UPDRS | 4.1 (4.3) | 27.9 (11.7) | −7.8 (25) | <0.0001 |
| LEDD | NA | 643.0 (372) | – | – |
| Best visual acuity | 1.06 (0.2) | 1.01 (0.2) | 0.56 (20) | 0.58 |
| Contrast sensitivity (both eyes) | 1.82 (0.14) | 1.82 (0.19) | –0.11 (21) | 0.91 |
| MOCA (baseline) | 28.9 (1.6) | 28.9 (1.2) | 0.009 (14.5) | 0.99 |
| MOCA (follow‐up) ( | 28.4 (1.5) (7) | 28.3 (1.5) (9) | 0.13 (13) | 0.90 |
| Time to MOCA follow‐up (Months) | 12.4 (3.8) | 12.6 (2.9) | −0.15 (9) | 0.89 |
Df, degrees of freedom; H&Y, Hoehn and Yahr; LEDD, Levodopa equivalent dose; MDS‐UPDRS, movement disorder society unified Parkinson's disease rating scale; MOCA, Montreal cognitive assessment; PD, Parkinson's disease; SD, standard deviation.
Data from one control participant not available.
P < 0.05.
Figure 1Experimental task. (A) Each trial started with a plain gray screen with a central fixation cross for 400 msec. On each trial, a different image of a cat or dog was shown that was skewed by a variable amount (four levels of skew between 0 a.u. and 2.8 a.u., defined in pilot sessions), order pseudorandomized. The image was shown for 280 msec. This was followed up by a screen with the letters C and D, indicating cat and dog. Participants indicated whether they had seen a cat or a dog by pressing a key on a response pad whilst inside the scanner. (B) Control trials with noisy images were identical in structure, but increasing amounts of visual noise were added (four levels of noise: between 0 and 1.2 a.u., defined in pilot sessions).
Performance in skew and visual noise tasks
| Level | Performance in controls | PD high performers | PD low performers |
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
| Skew task | |||||||||
| Skew 1 | 2.12 (0.37) | 2.30 (0.22) | 1.51 (0.46) | −1.4 (15) | 0.17 | 3.0 (13) | 0.010 | 4.48 (9) | 0.0014 |
| Skew 2 | 1.60 (0.56) | 1.52 (0.31) | 0.59 (0.64) | 0.39 (14) | 0.70 | 3.51 (14) | 0.0035 | 3.8 (9) | 0.0039 |
| Skew 3 | 0.70 (0.5) | 0.82 (0.50) | 0.33 (0.40) | −0.56 (19) | 0.58 | 1.7 (16) | 0.10 | 2.4 (17) | 0.028 |
| Skew 4 | 0.61 (0.41) | 0.65 (0.38) | 0.29 (0.24) | −0.22 (18) | 0.82 | 2.0 (15) | 0.058 | 2.5 (17) | 0.022 |
| Visual noise task | |||||||||
| Noise 1 | 1.94 (0.36) | 2.07 (0.42) | 1.56 (0.46) | −0.74 (19) | 0.47 | 1.9 (13) | 0.073 | 2.5 (14) | 0.025 |
| Noise 2 | 1.22 (0.55) | 1.24 (0.51) | 0.44 (0.52) | −0.09 (18) | 0.94 | 3.1 (16) | 0.0072 | 3.4 (15) | 0.0042 |
| Noise 3 | 0.082 (0.57) | −0.056 (0.27) | −0.18 (0.66) | 0.70 (13) | 0.50 | 0.89 (14) | 0.39 | 0.50 (9) | 0.63 |
| Noise 4 | −0.013 (0.53) | 0.067 (0.33) | −0.066 (0.31) | −0.41 (15) | 0.69 | 0.27 (15) | 0.79 | 0.90 (16) | 0.38 |
Performance at each level of skew and each level of the blur task, in each of the three groups, measured using d prime: unaffected controls, and Parkinson's participants in the high‐ and low‐performance groups. Note that groups were defined by performance at the second skew level (Skew 2), using alternate (odd‐numbered) trials. Data at the second level of skew shown here are therefore for even trials.
Df, degrees of freedom; PD, Parkinson's disease; vs, versus.
P < 0.05.
Figure 2Relationship between baseline performance in the skew task and change in MoCA after 12‐month follow‐up.
Figure 3Neural correlates of skew performance. (A) SPM showing main effect of increasing difficulty across tasks in unaffected individuals, overlaid on the mean T1 image of all participants. Threshold for display < 0.001 uncorrected. (B) SPM showing the interaction of skew task and increasing difficulty in unaffected individuals, overlaid on the mean T1 image of all participants. Threshold for display < 0.001 uncorrected. Scale bars represent T value of coordinates.
Figure 4Neural correlates of skew performance in high‐ versus low‐performing Parkinson's patients. SPM showing greater BOLD activity in high‐ versus low‐performing Parkinson's patients in the left parietal (A) and prefrontal regions (B). Threshold for display < 0.001 uncorrected, with cluster level correction applied. Scale bar represents T value of coordinates.
Movement parameters in each dimension for participants at low risk versus high risk for dementia in Parkinson's disease
| Axis | Low‐risk PD | High‐risk PD |
|
|
|---|---|---|---|---|
|
| 0.051 (0.05) | 0.025 (0.02) | 1.5 | 0.18 |
|
| 0.049 (0.007) | 0.038 (0.02) | 1.5 | 0.17 |
|
| 0.16 (0.2) | 0.091 (0.05) | 1.0 | 0.34 |
| Roll (SD) (deg) | 0.091 (0.04) | 0.076 (0.08) | 0.57 | 0.57 |
| Pitch (SD) (deg) | 0.056 (0.03) | 0.029 (0.02) | 2.0 | 0.074 |
| Yaw (SD) (deg) | 0.052 (0.03) | 0.031 (0.03) | 1.6 | 0.13 |
Values are mean scan‐to‐scan movements in mm or degrees.
Figure 5Psychophysiological interactions. SPM showing difference in functional connectivity to seed voxel identified in Figure 3B between high‐ and low‐performing patients with Parkinson's disease. Thresholded at < 0.001 uncorrected for display, with cluster level correction applied. Scale bar represents T value of coordinates.